Population Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-Analysis.

Population Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-Analysis.

<h4>Background</h4>Artemisinin-based combination therapies (ACTs) are the mainstay of the current treatment of uncomplicated Plasmodium falciparum malaria, but ACT resistance is spreading across Southeast Asia. Dihydroartemisinin-piperaquine is one of the five ACTs currently recommended...

Full description

Bibliographic Details
Main Authors:	Richard M Hoglund, Lesley Workman, Michael D Edstein, Nguyen Xuan Thanh, Nguyen Ngoc Quang, Issaka Zongo, Jean Bosco Ouedraogo, Steffen Borrmann, Leah Mwai, Christian Nsanzabana, Ric N Price, Prabin Dahal, Nancy C Sambol, Sunil Parikh, Francois Nosten, Elizabeth A Ashley, Aung Pyae Phyo, Khin Maung Lwin, Rose McGready, Nicholas P J Day, Philippe J Guerin, Nicholas J White, Karen I Barnes, Joel Tarning
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2017-01-01
Series:	PLoS Medicine
Online Access:	https://doi.org/10.1371/journal.pmed.1002212

Similar Items

Population pharmacokinetic properties of Piperaquine in Falciparum Malaria: an individual participant data-level meta-analysis
by: Hoglund, R, et al.
Published: (2017)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine.
by: Issaka Zongo, et al.
Published: (2014-01-01)

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria
by: Tarning, J, et al.
Published: (2012)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine
by: Zongo, I, et al.
Published: (2014)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria
by: Adam, I, et al.
Published: (2012)

Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
by: Palang Chotsiri, et al.
Published: (2019-01-01)

Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
by: Tarning, J, et al.
Published: (2012)

Quantification of the antimalarial piperaquine in plasma.
by: Tarning, J, et al.
Published: (2008)

Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand.
by: Tarning, J, et al.
Published: (2014)

Population pharmacokinetics and antimalarial pharmacodynamics of piperaquine in patients with plasmodium vivax malaria in Thailand
by: Tarning, J, et al.
Published: (2014)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
by: Tarning, J, et al.
Published: (2012)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
by: Tarning, J, et al.
Published: (2012)

Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention.
by: Bergstrand, M, et al.
Published: (2014)

Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
by: Chotsiri, P, et al.
Published: (2019)

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria
by: Ashley, E, et al.
Published: (2010)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria.
by: Adam, I, et al.
Published: (2012)

Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
by: Rijken, M, et al.
Published: (2011)

Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
by: Tarning, J, et al.
Published: (2008)

Randomized noninferiority trial of dihydroartemisinin-piperaquine compared with sulfadoxine-pyrimethamine plus amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso
by: Zongo, I, et al.
Published: (2015)

Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers
by: Chotsiri, P, et al.
Published: (2017)

Pitfalls in estimating piperaquine elimination.
by: Tarning, J, et al.
Published: (2005)

Comparison of lumefantrine, mefloquine, and piperaquine concentrations between capillary plasma and venous plasma samples in pregnant women with uncomplicated falciparum and vivax malaria
by: Saito, M, et al.
Published: (2024)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria.
by: Lwin, K, et al.
Published: (2012)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria
by: Lwin, K, et al.
Published: (2012)

Rethinking Dosing Regimen Selection of Piperaquine for Malaria Chemoprevention: A Simulation Study.
by: Nancy C Sambol, et al.
Published: (2016-01-01)

Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.
by: Tarning, J, et al.
Published: (2014)

Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine
by: Byakika-Kibwika, P, et al.
Published: (2019)

Semimechanistic pharmacokinetic and pharmacodynamic modeling of piperaquine in a volunteer infection study with Plasmodium falciparum blood-stage malaria
by: Wattanakul, T, et al.
Published: (2021)

A small amount of fat does not affect piperaquine exposure in patients with malaria.
by: Annerberg, A, et al.
Published: (2011)

A small amount of fat does not affect piperaquine exposure in patients with malaria.
by: Annerberg, A, et al.
Published: (2011)

Impact of dolutegravir-based antiretroviral therapy on piperaquine exposure following dihydroartemisinin-piperaquine intermittent preventive treatment of malaria in pregnant women living with HIV
by: Banda, CG, et al.
Published: (2022)

Characterization of human urinary metabolites of the antimalarial piperaquine.
by: Tarning, J, et al.
Published: (2006)

Clinical impact of vivax malaria: A collection review.
by: Aung Pyae Phyo, et al.
Published: (2022-01-01)

Pharmacokinetic evaluation and metabolite characterization of the antimalarial piperaquine in the rat
by: Tarning, J, et al.
Published: (2007)

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria.
by: Ashley, E, et al.
Published: (2010)

Prediction of improved antimalarial chemoprevention with weekly dosing of dihydroartemisinin-piperaquine.
by: Permala, J, et al.
Published: (2017)

In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1.
by: Mwai, L, et al.
Published: (2009)

A RANDOMISED, DOUBLE-BLIND PLACEBO CONTROLLED TRIAL OF TWO DIFFERENT DOSING REGIMENS OF DIHYDROARTEMISININ-PIPERAQUINE FOR INTERMITTENT PREVENTIVE TREATMENT OF ADULTS AT HIGH RISK OF MALARIA IN THAILAND
by: Lwin, K, et al.
Published: (2010)

Population pharmacokinetics of piperaquine after two different treatment regimens of dihydroartemisinin piperaquine in patients with acute uncomplicated falciparum malaria in Thailand
by: Tarning, J, et al.
Published: (2007)

A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border
by: Makoto Saito, et al.
Published: (2021-06-01)